Granted Patent B2

US 12,582,376 · App. 17/888,031 · Granted Mar 24, 2026

Inventor: Clinton T. Siedenburg (Everett, WA)

Assignee: Stryker Corporation

A61B8/04A61B8/0891A61B8/5223A61B8/06A61B8/4236A61B8/56

Abstract

Claims (51)

1 . A medical device, comprising:

a sensor comprising:

an emitter configured to emit a signal toward a blood vessel of a patient;

a detector configured to detect a reflection of the signal from the blood vessel of the patient; and

a processor configured to:

determine, by analyzing the reflection of the signal from the blood vessel of the patient, a systolic geometric parameter of the blood vessel during a systole phase of a cardiac cycle;

determine, by analyzing the reflection of the signal from the blood vessel of the patient, a diastolic geometric parameter of the blood vessel during a diastole phase of the cardiac cycle;

determine a quotient of the diastolic geometric parameter over a difference between the systolic geometric parameter and the diastolic geometric parameter; and

determine a pulse wave velocity by multiplying the quotient by a change in blood flow in the blood vessel.

2 . The medical device of claim 1 , wherein the emitter is configured to emit ultrasound.

3 . The medical device of claim 1 , wherein the emitter is configured to emit the signal in a single beam;

wherein the reflection of the signal is a reflection of the single beam by a single location of the blood vessel.

4 . The medical device of claim 1 , further comprising:

a single ultrasound transducer comprising the emitter and the detector.

5 . The medical device of claim 1 , the emitter being a first emitter, the detector being a first detector, the medical device further comprising: a linear array of ultrasound transducers comprising the first emitter, the first detector, a second emitter, and a second detector.

6 . The medical device of claim 1 , wherein the systolic geometric parameter of the blood vessel comprises an inner diameter of the blood vessel, an outer diameter of the blood vessel, a cross-sectional area of the blood vessel, or a thickness of a wall of the blood vessel.

7 . The medical device of claim 1 , wherein the processor is further configured to:

determine, by analyzing the reflection of the signal, a velocity of blood in the blood vessel; and

determine a blood pressure of the patient the pulse wave velocity and the velocity of the blood in the blood vessel.

8 . The medical device of claim 1 , wherein the sensor or the processor is comprised in a patch configured to be attached to the patient.

9 . The medical device of claim 8 , wherein the patch comprises a self-dispensing a wetting agent, the patch being further configured to dispense at least a portion of the wetting agent on the patient when the patch is attached to the patient or as the patch is being attached to the patient.

10 . The medical device of claim 1 , wherein the sensor is wirelessly coupled to the processor and further comprises a communicator configured to send and receive data transmitted between the detector and the processor.

11 . The medical device of claim 10 , wherein the data transmitted between the sensor and the processor indicates the reflection of the signal.

12 . The medical device of claim 10 , wherein the data indicates the reflection of the signal, the systolic geometric parameter of the blood vessel, the diastolic geometric parameter of the blood vessel, or the pulse wave velocity of the patient.

13 . The medical device of claim 1 , wherein the systolic geometric parameter comprises a cross-sectional area of the blood vessel during the systole phase; and

wherein the diastolic geometric parameter comprises a cross-sectional area of the blood vessel during the diastole phase.

14 . The medical device of claim 1 , wherein the pulse wave velocity is proportional to the quotient.

15 . The medical device of claim 1 , wherein the processor is further configured to:

determine the change in the blood flow in the blood vessel by determining a difference between a systolic blood flow in the blood vessel and a diastolic blood flow in the blood vessel.

16 . The medical device of claim 1 , wherein the systolic geometric parameter comprises a peak geometric parameter of the blood vessel during the systole phase, and

wherein the diastolic geometric parameter comprises a geometric parameter of the blood vessel at an end of the diastole phase.

17 . A method of measuring non-invasive blood pressure (NIBP) in a patient without restricting a blood vessel of the patient, comprising:

emitting a signal toward a single location of a blood vessel of the patient;

receiving a reflection of the signal from the single location of the blood;

determining, by analyzing the reflection of the signal, a systolic geometric parameter of the blood vessel during a systole phase of a cardiac cycle;

determining, by analyzing the reflection of the signal, a diastolic geometric parameter of the blood vessel during a diastole phase of the cardiac cycle;

determining a quotient of the diastolic geometric parameter over a difference between the systolic geometric parameter and the diastolic geometric parameter; and

determining a pulse wave velocity by multiplying the quotient by a change in blood flow in the blood vessel.

18 . The method of claim 17 , further comprising:

determining the change in the blood flow in the blood vessel by determining a difference between a systolic blood flow in the blood vessel and a diastolic blood flow in the blood vessel.

19 . A medical device, comprising:

a sensor comprising:

an emitter configured to emit a signal towards a single location of a blood vessel of a patient; and

a detector configured to detect a reflection of the signal from the single location of the blood vessel; and

a processor configured to:

determine, by analyzing a portion of the reflection of the signal detected by the detector at a first time associated with a systole phase of a cardiac cycle, a systolic geometric parameter of the blood vessel during the systole phase;

determine, by analyzing a portion of the reflection of the signal detected by the detector at a second time associated with a diastole phase of the cardiac cycle, a diastolic geometric parameter of the blood vessel during the diastole phase;

determine a quotient of the diastolic geometric parameter over a difference between the systolic geometric parameter and the diastolic geometric parameter;

determine a change in blood flow in the blood vessel by determining a difference between a systolic blood flow in the blood vessel and a diastolic blood flow in the blood vessel; and

determine a pulse wave velocity by multiplying the quotient by the change in the blood flow in the blood vessel.

20 . The medical device of claim 19 , wherein the signal comprises light or ultrasound.

Assignments (2)

Continuity (3)

References Cited (241)